Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
26 results
D1.64 - Distinct and Overlapping Sensitization Patterns to Crustacean and House Dust Mite Allergens in Tropical Allergy
D1.75 - Association of SCORAD Values with Skin Barrier Function Indicators in Patients with Atopic Dermatitis
D1.61 - Shrimp Tropomyosin as a Selective Allergen in a Case of Food Allergy: The Value of Individualized Molecular Analysis
D1.62 - Thermal stress alters the allergen and proteome profile of the redclaw crayfish (Cherax quadicarinatus)
D1.65 - Selective Allergy to Large Prawn: Identification of a Projectin-Derived IgE-Binding Protein
D1.66 - Allergy profiling in selective goat and sheep milk allergy
D1.70 - IgE-sensitization to allergens in plant-based drinks in children with cow’s milk allergy
D1.71 - Can an allergist predict the development of allergies? A Clinical case of dizygotic twins with divergent outcomes
D1.73 - Date Palm or Grass pollen rhinoconjuctivitis in a patient with watermelon allergy?
D1.74 - Sunflower Seed–Induced Anaphylaxis: Allergenic Characterization and Evidence of Cross-Reactivity with Niger Seeds
D2.490 - Consistent efficacy of a seasonal 300IR birch pollen sublingual immunotherapy in children and adolescents during worst pollen exposure: results of the YOBI trial
D2.491 - Efficacy of a 300IR birch liquid sublingual immunotherapy during the alder and hazel pollen seasons: results of the YOBI trial
D2.492 - Efficacy and safety of a 300IR daily dose of a SLIT of birch pollen allergen extract in children and adolescents with allergic rhinoconjunctivitis: results from the YOBI trial
D2.494 - Tralokinumab treatment in adults with atopic dermatitis who were previously treated with dupilumab: 12-months real-world data from the TRACE study
D2.496 - First-in-Human Phase I Clinical Outcomes of BxC-I17e Enriched with HSP70/miR-22-3p in Atopic Dermatitis
D2.497 - Oral Deucrictibant Immediate-Release Capsule for On-Demand Treatment of Hereditary Angioedema Attacks: Results of the Phase 3 RAPIDe-3 Trial
D2.498 - Berotralstat Decreased HAE Attacks Treated with On-Demand Therapy or Utilizing Professional Care in Pediatric Patients Aged 2 to
D2.503 - LP-003 Injection for the treatment of H1 Antihistamine-Inadequately Controlled Chronic Spontaneous Urticaria (CSU): A Multicenter, Randomized, Double-Blind, Controlled Phase Ⅱ Study
D3.288 - Evaluating the role of dust mite sensitization in the development of edible insect allergies
D3.289 - Tolerance Assessment in Children with IgE-Mediated Cow's Milk Allergy Using Different Cutoff Values of Cow’s Milk Specific IgE
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download